These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19359042)
1. Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3. Groot AJ; El Khattabi M; Sachs N; van der Groep P; van der Wall E; van Diest PJ; Sonnenberg A; Verrips CT; Vooijs M Mol Immunol; 2009 Jun; 46(10):2022-8. PubMed ID: 19359042 [TBL] [Abstract][Full Text] [Related]
2. Lateral recognition of a dye hapten by a llama VHH domain. Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862 [TBL] [Abstract][Full Text] [Related]
4. A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers. Kastelic D; Frković-Grazio S; Baty D; Truan G; Komel R; Pompon D J Immunol Methods; 2009 Oct; 350(1-2):54-62. PubMed ID: 19744487 [TBL] [Abstract][Full Text] [Related]
6. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama. Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233 [TBL] [Abstract][Full Text] [Related]
7. Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid. Winichayakul S; Pernthaner A; Scott R; Vlaming R; Roberts N Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):111-22. PubMed ID: 18844608 [TBL] [Abstract][Full Text] [Related]
8. Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment. Szynol A; de Haard JJ; Veerman EC; de Soet JJ; van Nieuw Amerongen AV Chem Biol Drug Des; 2006 Jun; 67(6):425-31. PubMed ID: 16882317 [TBL] [Abstract][Full Text] [Related]
9. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Coppieters K; Dreier T; Silence K; de Haard H; Lauwereys M; Casteels P; Beirnaert E; Jonckheere H; Van de Wiele C; Staelens L; Hostens J; Revets H; Remaut E; Elewaut D; Rottiers P Arthritis Rheum; 2006 Jun; 54(6):1856-66. PubMed ID: 16736523 [TBL] [Abstract][Full Text] [Related]
10. Llama single domain antibodies as a tool for molecular mimicry. Zarebski LM; Urrutia M; Goldbaum FA J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359 [TBL] [Abstract][Full Text] [Related]
11. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure. Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039 [TBL] [Abstract][Full Text] [Related]
12. Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Dolk E; van Vliet C; Perez JM; Vriend G; Darbon H; Ferrat G; Cambillau C; Frenken LG; Verrips T Proteins; 2005 May; 59(3):555-64. PubMed ID: 15778955 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries. Krüger C; Hultberg A; Marcotte H; Hermans P; Bezemer S; Frenken LG; Hammarström L Appl Microbiol Biotechnol; 2006 Oct; 72(4):732-7. PubMed ID: 16636830 [TBL] [Abstract][Full Text] [Related]
14. Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins. Harmsen MM; Van Solt CB; Fijten HP; Van Setten MC Vaccine; 2005 Sep; 23(41):4926-34. PubMed ID: 15992972 [TBL] [Abstract][Full Text] [Related]
15. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies. Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828 [TBL] [Abstract][Full Text] [Related]
16. Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis. Fatima A; Wang H; Kang K; Xia L; Wang Y; Ye W; Wang J; Wang X PLoS One; 2014; 9(4):e95263. PubMed ID: 24751715 [TBL] [Abstract][Full Text] [Related]
17. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides. Qin W; Feng J; Li Y; Lin Z; Shen B Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837 [TBL] [Abstract][Full Text] [Related]
18. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition. Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059 [TBL] [Abstract][Full Text] [Related]
19. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of chymosin secretion by simultaneous expression with chymosin-binding llama single-domain antibody fragments in yeast. Harmsen MM; Smits CB; de Geus B Appl Microbiol Biotechnol; 2002 Dec; 60(4):449-54. PubMed ID: 12466886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]